Multiple sclerosis patients and COVID-19.

Published in: The Egyptian journal of neurology, psychiatry and neurosurgery (2021)

Coronavirus disease 2019 (COVID-19) is now a major issue for all fields of medicine. Due to the higher mortality rate among patients with chronic diseases, it has also caused concern in patients with multiple sclerosis (MS), who in addition are often receiving immunosuppressive drugs. The aim of this article is to discuss what is currently known about the severity of COVID-19 in MS patients.

Keyphrases

coronavirus disease
multiple sclerosis
end stage renal disease
sars cov
ejection fraction
chronic kidney disease
newly diagnosed
mass spectrometry
ms ms
peritoneal dialysis
cardiovascular disease
coronary artery disease
drug induced